Fortress Biotech Stock Price. Everything You Need To Know About The Fortress Biotech Stock!
Fortress Biotech, Inc. is a pharmaceutical company that specializes in the manufacture and commercialization of novel pharmaceutical products and product candidates. Based in Bay Harbor Islands, Florida, the company currently employs 187 full-time employees. Fortress went public on November 17th, 2011 and has since developed a strong reputation in the pharmaceutical industry.
Fortress has a broad portfolio of products, including nine prescription pharmaceutical products on the market and over 30 programs in development at Fortress and its partner companies. These products and candidates are used in a range of therapeutic areas, including oncology, rare diseases, and gene therapy.
Some of Fortress’s commercialized products include Qbrexza, a medicated cloth towelette that treats axillary hyperhidrosis; Accutane, an oral retinoid that treats severe recalcitrant nodular acne; Ximino, an extended-release capsule that treats inflammatory lesions of non-nodular moderate to severe acne vulgaris; and Targadox, a tetracycline-class drug used as adjunctive therapy for severe acne.
Fortress operates in two segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. By staying informed about Fortress Biotech’s products, pipeline, and stock price today, you can make more informed decisions about investing in the pharmaceutical industry. And, if you’re someone who’s looking for innovative treatments for rare diseases or other medical conditions, Fortress Biotech’s products and candidates might be worth exploring.
Fortress Biotech Stock Price. Everything You Need To Know About The Fortress Biotech Stock! performance
- Employees 187
- Company HQ Bay Harbor Islands
- Website http://www.fortressbiotech.com
- FBIO Asset Type Common Stock
- FBIO Market Capitalization 33.1M
- Earnings Per Share -8.47
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Looking to invest in the promising field of biotechnology? Fortress Biotech may be the perfect opportunity for investors from Malaysia, Thailand, Indonesia, and Vietnam. As a renowned investment platform, Zorion offers unique insights and recommendations for retail investors, ensuring informed decisions about their investment choices. Fortress Biotech specializes in developing and commercializing innovative biopharmaceutical products, focusing on therapeutic areas with significant unmet medical needs. With Zorion’s investment resources and educational materials, retail investors can enhance their knowledge about Fortress Biotech and make well-informed investment decisions. Take advantage of this exciting opportunity and learn how to invest in Fortress Biotech from Malaysia, Thailand, Indonesia, and Vietnam through Zorion’s accessible platform.
